Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 14:14:593-606.
doi: 10.1515/med-2019-0067. eCollection 2019.

Prediction of Recurrence-associated Death from Localized Prostate Cancer with a Charlson Comorbidity Index-reinforced Machine Learning Model

Affiliations

Prediction of Recurrence-associated Death from Localized Prostate Cancer with a Charlson Comorbidity Index-reinforced Machine Learning Model

Yi-Ting Lin et al. Open Med (Wars). .

Abstract

Research has failed to resolve the dilemma experienced by localized prostate cancer patients who must choose between radical prostatectomy (RP) and external beam radiotherapy (RT). Because the Charlson Comorbidity Index (CCI) is a measurable factor that affects survival events, this research seeks to validate the potential of the CCI to improve the accuracy of various prediction models. Thus, we employed the Cox proportional hazard model and machine learning methods, including random forest (RF) and support vector machine (SVM), to model the data of medical records in the National Health Insurance Research Database (NHIRD). In total, 8581 individuals were enrolled, of whom 4879 had received RP and 3702 had received RT. Patients in the RT group were older and exhibited higher CCI scores and higher incidences of some CCI items. Moderate-to-severe liver disease, dementia, congestive heart failure, chronic pulmonary disease, and cerebrovascular disease all increase the risk of overall death in the Cox hazard model. The CCI-reinforced SVM and RF models are 85.18% and 81.76% accurate, respectively, whereas the SVM and RF models without the use of the CCI are relatively less accurate, at 75.81% and 74.83%, respectively. Therefore, CCI and some of its items are useful predictors of overall and prostate-cancer-specific survival and could constitute valuable features for machine-learning modeling.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Conflict of interest statement: Authors state no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of subjects searching This figure demonstrates whole procedure for establishing our target population. The dataset of target population was extracted from the outpatient expense file, hospitalization expense file, TCR file and death cause file of NHIRD.
Figure 2
Figure 2
Accumulated mortality events curve, stratified initial definite treatment, grade, stage and years Mortality events are significantly higher in high grade, RT group. Grade 1: Gleason score 2~5; Grade 2: Gleason score 6,7; Grade 3: Gleason score 8~10 *: Statistically significant, p<0.05

References

    1. Lehto US, Ojanen M, Vakeva A, Dyba T, Aromaa A, Kellokumpu-Lehtinen P. Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer. Qual Life Res. 2019;28(3):677. –. - PMC - PubMed
    1. Adam S, Feller A, Rohmman S, Arndt V. Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review. Health Qual Life Outcomes. 2018;16(1):22. - PMC - PubMed
    1. Serrell EC, Pitts D, Hayn M, Beaule L, Hansen MH, Sammon JD. Review of the comparative effectiveness of radical prostatectomy, radiation therapy, or expectant management of localized prostate cancer in registry data. Urol Oncol. 2018;36(4):183. –. - PubMed
    1. Wallis CJ, Glaser A, Hu JC, Huland H, Lawrentschuk N, Moon D. Survival and complications following surgery and radiation for localized prostate cancer: an international collaborative review. European urology. 2018;73(1):11. et al. –. - PubMed
    1. Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Computational and structural biotechnology journal. 2015;13:8. –. - PMC - PubMed

LinkOut - more resources